Search

everythinglearnresearchcommunity

for

Search:↓

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Male pattern baldness affects 38.52% of Asian men in Bangkok, increasing with age and possibly linked to environment and diet.

1 mg/day of low-dose oral minoxidil is effective and safe for treating female hair loss.

Hair loss in men (androgenetic alopecia) is significantly linked to decreased scalp sensitivity, but not temperature sensitivity. More research is needed to confirm this. Comparing this hair loss to leprosy is unsupported and stigmatizing.

Oral minoxidil may be a better treatment for hair loss than topical minoxidil.

Scalp nerve issues are linked to hair loss in men.

PRP injections can help increase hair density and thickness in men with hair loss.

Minimally invasive procedures may help with female hair loss but need more research and should be done by experts.

Low-energy fractional CO2 laser therapy significantly improves hair regrowth in women with female-pattern hair loss.

Both PRP and MZT treatments can significantly improve hair growth in patients with androgenetic alopecia.

The document suggests that nerve issues might contribute to hair loss and that testing sensation could predict these nerve problems.

The report concludes that atypical Brauer nevus is more common in males, present at birth, and often misdiagnosed due to its unusual scalp locations.

Women's hair generally gets thinner and less dense starting in their mid-thirties, with hair loss becoming more common as they age due to both genetics and environment.

Male androgenetic alopecia (MAA) is a common, hereditary hair loss condition in men, linked to heart disease, and can be treated with minoxidil, finasteride, or hair transplantation.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

Various potential triggers may be causing the rise in frontal fibrosing alopecia, and avoiding these could help stop the disease's increase.

Male hair loss is mainly due to thinner hair, not less hair.

Hair loss is due to thinner hairs, not less hairs; hair diameter indicates balding progression and treatment effectiveness.

Female pattern hair loss can be treated with medications, surgery, and cosmetic products, considering its psychological impact.

Multiple treatments work best for hair loss.

New model shows muscle affects hair loss differently in men and women.

The hair shedding scale accurately identifies abnormal hair shedding in women with long hair, with grades 5 and 6 indicating excessive shedding.

Flutamide improves female hair loss when other treatments fail, but may cause liver toxicity.

Spironolactone and minoxidil together effectively treat female pattern hair loss.

Alternative treatments show promise for hair growth beyond traditional methods.

Two gene variations, rs6493497 and rs7176005, may be linked to female hair loss in Chinese people.

Vitamin D may help reduce antibody levels in men with autoimmune thyroiditis and early-onset androgenic alopecia, but has no significant impact on thyroid function.

No significant link between CAG repeat numbers and female pattern hair loss in Han Chinese population.

Delaying hair loss treatment reduces its effectiveness.

Platelet-rich plasma is an effective and safe treatment for male pattern hair loss.